Navigation Links
New Migraine Drug Shows Promise
Date:8/14/2009

Orally inhaled therapy effective with few side effects, study finds

FRIDAY, Aug. 14 (HealthDay News) -- An experimental inhaled drug called Levadex is an effective treatment for migraines, according to a drug company-funded study.

The phase III trial, conducted at the Jefferson Headache Center at Thomas Jefferson University Hospital in Philadelphia, found that migraine patients who took the drug had greater relief from symptoms such as pain, nausea and light/sound sensitivity than those who took a placebo.

The drug provided pain relief within 30 minutes and sustained relief for 48 hours in patients with moderate or severe migraines. There were no drug-related, serious adverse effects, according to a news release issued by the university.

"The major advantage of Levadex is that it has the efficacy of intravenous DHE (dihydroergotamine) with a side-effect profile similar to placebo and better than oral triptans," Dr. Stephen Silberstein, director of the Jefferson Headache Center, and professor in the neurology department at Jefferson Medical College, said in the news release.

The study was funded by MAP Pharmaceuticals, Inc. Silberstein serves on the advisory board of the company.

More information

The American Academy of Family Physicians has more about migraine.



-- Robert Preidt



SOURCE: Thomas Jefferson University, news release, Aug. 11, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Page: 1

Related medicine news :

1. Neuromuscular Dentistry Ends Womans Migraines
2. Migraine Tied to Thickening in Brain Area
3. Business Coalition Honors BlueChoice HealthPlan for Migraine Program
4. The HealthCentral Network Wins eHealthcare Awards for Breast Cancer and Migraine Web Sites
5. MAP Pharmaceuticals Reaches Agreement with FDA on Special Protocol Assessment for MAP0004 Phase 3 Clinical Trial in Patients With Migraine
6. Comatose locusts may help relieve migraines
7. Epilepsy Drug Doesnt Prevent Migraines
8. MyMigraineConnection.com and Migraine Expert Teri Robert Announce Seventh Annual Migraine and Headache Poetry Contest
9. Migraines Frequency Influences Heart Attack, Stroke Risk
10. Overuse of Opioids, Barbiturates Boosts Chronic Migraine Risk
11. Skin Pain, Sensitivity Rises With Migraine
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New Migraine Drug  Shows Promise
(Date:2/20/2017)... ... February 20, 2017 , ... Best Doctors® and IBM ... benefit for companies that want to help members of their workforce battling cancer. ... access to Watson’s suite of oncology offerings for insights on cancer treatment options, ...
(Date:2/20/2017)... ... February 20, 2017 , ... ... providers and health plan partners, announced during the 2017 Annual HIMSS Conference ... care coordination for diabetic patients and integrating eye care into mainstream healthcare ...
(Date:2/19/2017)... ... February 19, 2017 , ... "At your ... care, and MEDfx and the Delaware Health Information Network (DHIN) have partnered to ... nation’s first state-wide health information exchange, DHIN stores and shares real-time health data ...
(Date:2/18/2017)... ... February 17, 2017 , ... ... drvallecillos.com , Beverly Hills plastic surgeon Dr. Glenn Vallecillos experiments ... Dr. Vallecillos says, "Traditionally, plastic surgery has been centered around that idea that ...
(Date:2/17/2017)... ... February 17, 2017 , ... ... kept pace. Enovate Medical has introduced an innovative workstation designed to reduce nursing ... nurses, the Encore Mobile EHR Workstation offers a lightweight, highly mobile, multi-functional alternative ...
Breaking Medicine News(10 mins):
(Date:2/19/2017)... British Columbia , February 18, 2017 ... into an agreement to purchase a Medical Delivery Service ... or coordinate cannabis transactions between qualified patients and caregivers. ... Mirage , located in the Coachella Valley, ... Greater Los Angeles area to ...
(Date:2/18/2017)... HILL, N.C. , Feb. 17, 2017  Pharmaceutical companies ... insights about products either in development or already on the ... have forced the pharma industry to alter how it manages ... boards, consulting leader Best Practices, LLC conducted a new study ... ...
(Date:2/17/2017)... , Feb. 17, 2017 Arvinas LLC, ... drugs based on protein degradation, today announced the presentation ... (AR) PROTAC during a poster session at the American ... GU) in Orlando, FL. ... validate our platform and the potential of PROTACs to ...
Breaking Medicine Technology: